Underpinned by pharmaceutical-industry estimates that approximately 40% of lipophilic therapeutic molecules are rejected because of their poor aqueous solubility and formulation-stability issues, one of the main challenges facing modern pharmaceutical science is the development of carrier vehicles for the extended delivery of such drug candidates. Additional impetus for such research activities is provided by the potential of such carriers to improve the therapeutic profiles of many of the widely used hydrophobic chemotherapeutants. Nowday, carrier vehicles for the delivery of hydrophobic drugs are associated with several disadvantages: conventional emulsions, micelles and liposomes are thermodynamically unstable; lipophilic carriers cluster in blood flow and are rapidly opsonized and massively cleared by liver and spleen; loading capacity of hydrophobic drugs into hydrophilic carriers is limited. Rationalised in the terms of thermodynamic stability, capability to move through blood capillaries, imrpoved drug loading capacity, surface-charged hydrophilicity, and capacity to effect controlled drug release, one of the approaches towards addressing these issues involves the use of superabsorbent polyelectrolytes-based nanogels with affinity for both water and organic liquids. Towards the development of biomaterials for the delivery of hydrophobic drugs, in this project, biocompatible, polymerisable Room Temperature Ionic Liquids (RTILs) based on 1-vinylimidazole and amino acids, as well as nanoparticulate co-polymeric gels of the same RTILs and 2-hydroxyethyl methacrylate (HEMA)/1-vinyl-2-pyrrolidone (NVP) with superabsorbency for both water and several organic liquids will be synthesized and characterised. The suitability of the nanogels to be a novel delivery platform for hydrophobic/aqueously unstable drugs will be assessed in vitro in the terms of biocompatibility, drug uploading and release profiles.

A new compound derivative that can be used to form a unit molecular film as a rectifier in a molecular electronic device, a new rectifying compound (4,5,9,10-tetrahydro-pyren-2-yl)-carbamic acid 4-(2-methylsulfanyl-alkyl)-3,5-dinitro-benzyl ester and its derivative (4,5,9,10-Tetrahydro-pyren-2-yl)-carbamic acid 4-(2-methylsulfanyl-alkyl)-3,5-dinitro-benzyl ester, and methods of synthesizing the compounds are provided.

A new compound derivative that can be used to form a unit molecular film as a rectifier in a molecular electronic device, a new rectifying compound (4,5,9,10-tetrahydro-pyren-2-yl)-carbamic acid 4-(2-methylsulfanyl-alkyl)-3,5-dinitro-benzyl ester and its derivative (4,5,9,10-Tetrahydro-pyren-2-yl)-carbamic acid 4-(2-methylsulfanyl-alkyl)-3,5-dinitro-benzyl ester, and methods of synthesizing the compounds are provided.

A macromolecular architecture suitable for use in molecular electronics. And in the manufacture of conductors and semi-conductors has been synthesised using linear and branched oligomers of organic molecules. The incorporation of a bi-or tri-functional organic compound in an oligonucleotide chain and the application of these for formation of covalently linked organic and metal-organic oligomers has led to a novel molecular architecture. Furthermore, the iterative serial synthesis of linear and branched organic oligomers by automated methods such as DNA-synthesis or peptide synthesis, using bi- or tri-functional organic monomers is described herein. The novel compounds may be used to position and arrange nanoscale substrates such as biomolecules, biological structures, colloids, supramolecular structures forming covalently linked assemblies for use as conducting wires and components in electronic devices.

A complex comprising barnase bound with high affinity to barstar, and comprising a therapeutic and/or diagnostic agent bound to barnase and/or barstar.

Disclosed is a (meth)acrylate compound having excellent photocurability. Also disclosed is a curable composition using the (meth)acrylate compound, a cured film of which excels in pattern precision, releasability, surface hardness, elasticity recovery rate and solvent resistance. Further disclosed are a composition for optical nanoimprint, a cured product of the curable composition, and a method for producing the cured product. The composition is particularly suitable for a permanent film for flat panel displays or the like. Specifically disclosed is a (meth)acrylate compound represented by general formula (1). (1) (In the formula, R1 represents a hydrogen atom or a methyl group; R2 represents a substituent having 2-6 carbon atoms and a carbon-carbon double bond; X represents an organic group having 1-10 carbon atoms; and m and n respectively represent an integer of 1-3.)

It's object is to provide a (meth)acrylate compound excellent in photocurability, a curable composition comprising the compound and excellent in all of pattern accuracy, peelability, surface hardness, elasticity recovery and solvent resistance, an optical nanoimprint composition and a cured product of the curable composition and a method for producing it, especially to provide a composition favorable for a permanent film for flat panel displays, etc. A (meth)acrylate compound represented by the following formula (1): wherein R1 represents a hydrogen atom or a methyl group, R2 represents a substituent having carbon atoms of 2 to 6 and having a carbon-carbon double bond, X represents an organic group having carbon atoms of 1 to 10, m and n each are an integer of 1 to 3.

Novel articles and methods to fabricate the same resulting in flexible, large-area, [100] or [110] textured, semiconductor-based, electronic devices are disclosed. Potential applications of resulting articles are in areas of photovoltaic devices, flat-panel displays, thermophotovoltaic devices, ferroelectric devices, light emitting diode devices, computer hard disc drive devices, magnetoresistance based devices, photoluminescence based devices, non-volatile memory devices, dielectric devices, thermoelectric devices and quantum dot laser devices.